LAURA SMITH: Open Payments
NPI 1407502396 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,002 in 173 payments from 28 companies in 2025. Trend: 2023 $2,488 · 2024 $2,832 · 2025 $4,002
Food & beverage: $3,801Consulting: $150Education: $51
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $857 |
| GlaxoSmithKline, LLC. | 26 | $378 |
| HARMONY BIOSCIENCES LLC | 9 | $272 |
| Viatris Specialty LLC | 14 | $269 |
| Regeneron Healthcare Solutions, Inc. | 9 | $262 |
| Insmed, Inc. | 19 | $253 |
| GENZYME CORPORATION | 11 | $232 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $231 |
| JAZZ PHARMACEUTICALS INC. | 3 | $211 |
| Pulmonx Corporation | 1 | $150 |
Products named: DUPIXENT, FASENRA, WAKIX, YUPELRI, TEZSPIRE, Arikayce, XYWAV, NUCALA.
Industry payments across TN — which companies pay providers there.
